Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy
- Resource Type
- Article
- Source
- In
ESMO Open February 2022 7(1) - Subject
Thoracic Cancers - Language
- ISSN
- 2059-7029